Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAmeera shah

    Ameera Shah

    Jump to

    • Metropolis focuses on North India expansion, acquires Agra-based Scientific Pathology

      Scientific Pathology was the second acquisition in last three months in North India for Metropolis. The company has acquired Delhi NCR-based specialty cancer testing chain Core Diagnostics for Rs 247 crore through a combination of cash and stock in December last year.

    • Our focus remains on driving organic growth, says Metropolis Healthcare's Ameera Shah

      Metropolis Healthcare plans to add 90 new labs and 1,800 new collection centres by FY25

    • Do Big Symposium: Digital challenges & opportunities in India

      Tata Do Big Symposium 2016 travels to Mumbai, Hyderabad and Chennai on the quest to find out about the digital challenges and opportunities in India.

    • Carlyle Group buys 37% stake in Metropolis Healthcare

      An affiliate of Carlyle Asia Partners IV has bought a stake in Metropolis Healthcare Ltd, a multinational chain of pathology laboratories, Carlyle Group said in a statement.

    • Warburg sells 27% stake in Metropolis Healthcare

      Commenting on the development, Metropolis Healthcare Ltd MD & CEO Ameera Shah said, "Warburg Pincus invested in the company in 2010 and after nearly five years of support, sold its shares for handsome returns. "The shares have been acquired by me and my family. We are very excited about the new phase of growth."

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347